Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis (Q28217930)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Helen J Lachmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Laurence B. Lovat

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Simon Kolstoe

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

22

Wood SP

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Herbert J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Hutchinson WL

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Tennent GA

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Gallimore JR

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Bartfai T

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Alanine A

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Hertel C

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Hoffmann T

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Jakob-Roetne R

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Norcross RD

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Kemp JA

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Yamamura K

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Suzuki M

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Taylor GW

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Murray S

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Thompson D

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Purvis A

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Hawkins PN

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

417

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

254-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

6886

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP

9 November 2019

cites work

1 reference

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

21 April 2017

1 reference

WHAT IF: a molecular modeling and drug design program

21 April 2017

1 reference

PROCHECK: a program to check the stereochemical quality of protein structures

21 April 2017

1 reference

An extensively modified version of MolScript that includes greatly enhanced coloring capabilities

21 April 2017

1 reference

Raster3D Version 2.0. A program for photorealistic molecular graphics

21 April 2017

1 reference

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 April 2017

1 reference

Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis

21 April 2017

1 reference

MOLREP: an Automated Program for Molecular Replacement

21 April 2017

1 reference

Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.

21 April 2017

1 reference

7 January 2021

Amyloidosis: a review of recent diagnostic and therapeutic developments

1 reference

7 January 2021

Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family

1 reference

7 January 2021

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

1 reference

7 January 2021

Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis

1 reference

7 January 2021

Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure

1 reference

7 January 2021

Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits

1 reference

7 January 2021

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

1 reference

7 January 2021

Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses

1 reference

7 January 2021

Structure of pentameric human serum amyloid P component

1 reference

7 January 2021

Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis

1 reference

7 January 2021

Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis

1 reference

7 January 2021

The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo

1 reference

7 January 2021

Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component

1 reference

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

7 January 2021

Serum amyloid P-component is an acute-phase reactant in the mouse

1 reference

7 January 2021

Serum amyloid P component in chronic renal failure and dialysis

1 reference

7 January 2021

Human serum amyloid P component is a single uncomplexed pentamer in whole serum

1 reference

7 January 2021

Rapid measurement of binding constants and heats of binding using a new titration calorimeter

1 reference

7 January 2021

Processing of X-ray diffraction data collected in oscillation mode

1 reference

7 January 2021

Liver-specific and high-level expression of human serum amyloid P component gene in transgenic mice

1 reference

7 January 2021

Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component

1 reference

7 January 2021

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component

1 reference

7 January 2021

Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation.

1 reference

7 January 2021

Identifiers

DOI

10.1038/417254A

2 references

Consolidated OpenCitations Corpus – April 2017

231499

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 November 2019

1002489408

0 references

231499

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

231499

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12015594%20AND%20SRC:MED&resulttype=core&format=json